pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Neurology · news · pharmadog
← back to Neurology
News · Neurology
268
stories
17d
Opinion: What happened to oppositional defiant disorder?
stat
18d
Novartis to pay $125M for blood-brain barrier crossing platform
biopharma dive
18d
Researchers implant human neurons in mice brains to study disease
endpoints
18d
STAT+: Scientists made mice with half a brain. Then they filled them with human organoids
stat
18d
Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month
biospace
18d
Skyhawk racks up more support for Huntington’s drug
biopharma dive
18d
Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
fiercebiotech
18d
Opinion: STAT+: Dementia should be a campaign issue — not an insult
stat
19d
A fourth measles death is reported in Pennsylvania
stat
19d
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
biospace
19d
Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
fiercebiotech
19d
Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech
fiercebiotech
20d
Judge blocks Trump administration plans to limit visa length for grad students, postdocs
stat
20d
Kennedy to deliver keynote for anti-vaccine group he once led
stat
20d
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more
stat
20d
Opinion: Am I a hypocrite for loving football despite CTE?
stat
20d
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
23d
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
stat
23d
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
23d
Beyond clinical endpoints: Rethinking ALS drug development through disease biology
fiercebiotech
24d
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label
endpoints
24d
Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill
stat
25d
Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
biospace
25d
GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing
fiercebiotech
26d
STAT+: Health care features prominently in Democrats’ agenda
stat
26d
Novartis’ $12B Avidity acquisition hits Phase 3 speedbump as dystrophy drug disappoints
biospace
26d
STAT+: Roivant lung disease drug hits mid-stage study goals
stat
26d
STAT+: UnitedHealth executives shower high-ranking Democrat with donations ahead of midterms
stat
26d
Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
biospace
27d
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
stat
← prev
page 2 of 9
next →
